Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Use of Transvaginal Resorbable Biologic Mesh as Compared to Traditional Non-Mesh Surgical Repair for Treating Pelvic Floor Disorders

NCT02021279 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT02021279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Use of Transvaginal Resorbable Biologic Mesh as Compared to Traditional Non-Mesh Surgical Repair for Treating Pelvic Floor Disorders
Lead sponsor
Integra LifeSciences Corporation
Phase
Not applicable
Overall status
Completed
Start date
June 11, 2014
Completion date
April 28, 2021
Enrollment
161 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse